Treatment of cirrhotic ascites

Acta Gastro-Enterologica Belgica

Volumn 70, Issue 2, 2007, Pages 217-222

  Schouten, J ^a   Michielsen, P P ^a  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALDOSTERONE ANTAGONIST; DIURETIC AGENT; FUROSEMIDE; LOOP DIURETIC AGENT; MINERALOCORTICOID ANTAGONIST; SPIRONOLACTONE;

ASCITES; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; DISEASE FREE SURVIVAL; DRUG DOSE INCREASE; DRUG MEGADOSE; ELECTROLYTE DISTURBANCE; GYNECOMASTIA; HEPATIC ENCEPHALOPATHY; HUMAN; HYPERALDOSTERONISM; HYPERKALEMIA; HYPOKALEMIA; HYPONATREMIA; KIDNEY FAILURE; LIVER CIRRHOSIS; LIVER GRAFT; METABOLIC ACIDOSIS; PARACENTESIS; PERIPHERAL EDEMA; RANDOMIZED CONTROLLED TRIAL; RECOMMENDED DRUG DOSE; SODIUM EXCRETION; SODIUM INTAKE; SODIUM RETENTION; WATER RETENTION; WEIGHT REDUCTION;

ASCITES; DIET, SODIUM-RESTRICTED; DIURETICS; HUMANS; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; PARACENTESIS; PROGNOSIS; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE;

EID: 34447500592     PISSN: 00015644     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (68)

1. REYNOLDS T.B. Ascites. Clin. Liver Dis., 2000, 4 : 151-168.
2. GINES P., QUINTERO E., ARROY V., TERES J., BRUGUERA M., RIMOLA A., CABALLERIA J., RODES J., ROZMAN C. Compensated cirrhosis : natural history and prognositic factors. Hepatology, 1987, 7 : 122-128.
3. SALERNO F., BORRONI G., MOSER P., BADALAMENTI S., CASSARA L., MAGGI A., FUSINIM., CESANA B. Survival and prognostic factors of cirrhotic patients with ascites : a study of 134 outpatients. Am. J. Gastroenterol., 1993, 88 : 514-519.
4. RUNYON B.A., MONTANO A.A., AKRIVIADIS E.A., ANTILLON M.R., IRVING M.A., MC HUTCHISON J.G. The serum-ascites albumin gradient is superior to the exudate-transudate concept in the differential diagnosis of ascites. Ann. Intern. Med., 1992, 117 : 215-220.
5. MOORE K.P., WONG P., GINES P., BERNARDI M., OCHS A., SALERNO P., ANGELI P., PORAYKO M., GARCIA-TSAO G., JIMENEZ W., PLANAS R., ARROYO V. The management of ascites in cirrhosis : report on the consensus conference of the International Ascites Club. Hepatology, 2003, 38 : 258-266.
6. RUNYON B.A. Management of adult patients with ascites due to cirrhosis. Hepatology, 2004, 39 : 841-56.
7. MOORE K.P., AITHAL G.P. Guidelines on the management of ascites in cirrhosis. Gut, 2006, 55 : 1-12.
8. CATTAU E., BENJAMIN S.B., KNURF T.E. The accuracy of the physical exam in the diagnosis of suspect ascites. JAMA, 1982, 247 : 1164-1166.
9. MC VAY, TOY P.T.C.Y. Lack of increased bleeding after paracentesis and thoracocentesis in patients with mild coagulation abnormalities. Transfusion, 1991, 13 : 164-171.
10. CARUNTU F.A., BENEA L. Spontaneous bacterial peritonitis : pathogenesis, diagnosis, treatment. J. Gastrointestin. Liver Dis., 2006, 15 : 51-6.
11. PRESS O.W., PRESS N.O., KAUFMAN S.D. Evaluation and management of chylous ascites. Ann. Intern. Med., 1982, 96 : 358-364.
12. DE SITTER L., RECTOR W.G. The significance of bloody ascites in patients with cirrhosis. Am. J. Gastroenterol., 1984, 79 : 136-8.
13. PINZELLO G., SIMONETTI R.G., CRAXI A., DIPIAZZA S., SPANO C., PAGLIARO L. Spontaneous bacterial peritonitis : A retrospective investigation in predominantly non-alcoholic patients. Hepatology, 1983, 3 : 545-549.
14. NAVASA M., RODES J. Bacterial infections in cirrhosis. Liver Int., 2004, 24 : 277-280,
15. RUNYON B.A., CANAWATI H.N., AKRIVIADIS E.A. Optimization of ascitic fluid culture technique. Gastroenterology, 1988, 95 : 1351-1355.
16. OZMEN S., DURSUN M., YILMAZ S. Spontaneous bacterial peritonitis : pathogenesis, diagnosis, and management. Acta Gastroenterol. Belg., 2006, 69 : 276-82.
17. DI BONITO L., FALCONIERI G., COLAUTTI I., BONIFACIO D., DUDINE S. The positive peritoneal effusion. A retrospective study of cytopathologic diagnoses with autopsy confirmation. Acta Cytol., 1993, 37 : 483.
18. RUNYON B.A., HOEFS J.C., MORGAN TR. Ascitic fluid analysis in the malignancy related ascites. Hepatology, 1988, 8 : 1104-1109.
19. RUNYON B.A., HOEFS JC. Ascitic fluid analysis before, during and after spontaneous bacterial peritonitis. Hepatology, 1985, 5 : 257-259.
20. BIMALJIT S.S., ARUN J.S. Management of ascites in cirrhosis. Clin. Liver Dis., 2005, 9 : 715-732.
21. ARROYO V. Pathophysiology, diagnosis and treatment of ascites in cirrhosis. Ann. Hepatol., 2002, 1 : 72-9.
22. BEKHEIRNIA M.R., SCHRIER R.W. Pathophysiology of water and sodium retention : edematous states with normal kidney function. Curr. Opin. Pharmacol., 2006, 6 : 202-7.
23. LALEMAN W., VAN LANDEGHEM L., WILMER A., FEVERY J., NEVENS F. Portal hypertension : from pathophysiology to clinical practice. Liver Int., 2005, 25 : 1079-90.
24. GROSZMANN R.J., ABRALDES J.G. Portal hypertension : from bedside to bench. J. Clin. Gastroenterol., 2005, 39 (4 Suppl 2) : S125-30.
25. RING-LARSEN H., HENDRIKSEN J.H., WILKEN C., CLAUSEN J., PALS H., CHRISTENSEN N.J. Diuretic treatment in decompensated cirrhosis and congestive heart failure : effect of posture. Br. Med. J., 1986, 292 : 1351-1353.
26. PLAUTH M., MERLI M., KONDRUP J., WEIMANN A., FERENCI P., MULLER M.J. ESPEN guidelines for nutrition in liver disease and transplantation. Clin. Nutr., 1997, 16 : 43-55.
27. REYNOLDS T.B., LIEBERMAN P.L., GOLDMAN A.R. Advantages of the treatment of ascites without sodium restriction and without complete removal of excess fluid. Gut, 1978, 19 : 549-553.
28. DESCOS L., GAUTHIER A., LEVY V.G., MICHEL H., QUINTON A., RUEFF B., FERMANIAN J. Comparison of six treatments of ascites in patients with liver cirrhosis. Hepatogastroenterology, 1983, 30 : 15-20.
29. GAUTHIER A., LEVY V.G., QUINTON A., MICHEL H., RUEFF B., DESCOS L., DURBEC J.P., FERMANIAN J., LANCRENON S. Salt or no salt in the treatment of cirrhotic ascites : a randomized study. Gut, 1986, 27 : 705-709.
30. BERNARDI M., LAFFI G., SALVAGNINI M., AZZENA G., BONATO S., MARRA P., TREVISANI F., GASBARRINI G., NACCARATO R., GENTILINI P. Efficacy and safety of the stepped care medical treatment of ascites in liver cirrhosis : a randomized controlled clinical trial comparing two diets with different sodium content. Liver, 1993, 13 : 156-162.
31. STRAUSS E., DE SA M.F., LACET C.M., CARTAPATTTDA DA SILVA E., DOS SANTOS R.W. Padronizacao de conduta terapeutica das ascites do hepatopata cronico. Estudo prospective de 100 casos. GED, 1985, 4 : 79-86.
32. GREGORY J., FOSTER K., TYLER H. The dietary and nutritional survey of British adults. London : HMSO, 1990.
33. PORCEL A., DIAZ P., RENDON P., MACIAS M., MARTIN-HERRERA L., GIRON-GONZALEZ J.A. Dilutional hyponatremia in patients with cirrhosis and ascites. Arch. Intern. Med., 2002, 162 : 323-328.
34. GERBES A.L., GULBERG V., GINES P., DECAUX G., GROSS P., GANDJINI H., DJIAN J. Therapy of hyponatremia in cirrhosis with a vasopressin receptor antagonist : a randomized double-blind multicenter trial. Gastroenterology, 2003, 124 : 933-9.
35. WONG F., BLEI A.T., BLENDIS L.M., THULUVATH P.J. A vasopressin receptor antagonist (VPA-985) improves serum sodium concentration in patients with hyponatremia : a multicenter, randomized, placebo-controlled trial. Hepatology, 2003, 37 : 182-91.
36. HORISBERGER J.D., GIEBISCH G. Potassium-sparing diuretics. Ren. Physiol., 1987, 10 : 198-220.
37. FOGEL M.R., SAWHNEY V.K., NEAL E.A., MILLER R.G., KNAUER C.M., GREGORY P.B. Diuresis in the ascitic patient : a randomized controlled trial of three regimens. J. Clin. Gastroenterol., 1981, 3 (Suppl 1): 73-80.
38. YAGI N., KIUCHI T., SATOH H., TERASHIMA Y., KENMOTSU H., SEKIKAWA H., TAKADA M. Bioavailability and diuretic effect of furosemide following administration of tablets and retarded capsules to human subjects. Biol. Pharm. Bull., 1996, 19 : 616-22.
39. ARROYO V., GINES P., GERBES A.L., DUDLEY F.J., GENTILINI P., LAFFI G., REYNOLDS T.B., RING-LARSEN H., SCHOLMERICH J. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. Hepatology, 1996, 23 : 164-176.
40. ANDRES T.B., JUAN C., THE PRACTICE PARAMETERS COMMITTEE OF THE AMERICAN COLLEGE OF GASTROENTEROLOGY. Hepatic encephalopathy. AJG, 2001, 96 : 1968-1976.
41. BERNARDI M., TREVISANI P., GASBARRINI A., GASBARRINI B. Hepatorenal disorders : the role of renin-angiotensin-aldosteron system. Semin. Liver Dis., 1994, 14 : 23-34.
42. ARRAYO V., GINES P., SALO J. A European survey on the treatment of ascites in cirrhosis. J. Hepatol., 1994, 21 : 667-672.
43. SANTOS J., PLANAS R., PARDO A. Spirinolactone alone or in combination with furasemide in the treatment of moderate ascites in nonazotemic cirrhosis. A randomized comparative study of efficacy and safety. J. Hepatol., 2003, 39 : 187-192.
44. PEREZ-AYUSO R.M., ARROYO V., PLANAS R., GAYA J., BORY F., RIMOLA A., RIVERA F., RODES J. Randomized comparative study of efficacy of furosemide versus spirinolactone in patients with liver cirrhosis and ascites. Gastroenterology, 1983, 84 : 961-968.
45. RUNYON B.A. Care of patients with ascites. N. Engl. J. Med., 1994, 330 : 337-342.
46. RUNYON B.A. Treatment of patients with cirrhosis and ascites. Semin. Liv. Dis., 1997, 17 : 249-260.
47. BERNARDI M., SERVADEI D., TREVISANI P., RUSTICALI A.G., GASBARRINI G. Importance of plasma aldosterone concentration on the natriuretic effect of spironolactone in patients with liver disease and cirrhosis. Digestion, 1985, 31 : 189-193.
48. GINES P., ARROYO V., QUINTERO E., PLANAS R., BORY F., CABRERA J., RIMOLA A., VIVER J., CAMPS J., JIMENEZ W. Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Results of a randomized study. Gastroenterology, 1987, 93 : 234-41.
49. SUNGAILA I., BARTLE W.R., WALKER S.E., DEANGELIS C., UETRECHT J., PAPPAS C., VIDINS E. Spironolactone pharmacokinetics and pharmacodynamics in patients with cirrhotic ascites. Gastroenterology, 1992, 102 : 1680-1685.
50. POCKROS P.J., REYNOLDS T.B. Rapid diuresis in patients with ascites from chronic liver disease : the importance of peripheral edema. Gastroenterology, 1986, 90 : 1827-1833.
51. PIRLICH M., SELBERG O., BOKER K., SCHWARTZ M., MULLER M.J. The creatinine approach to estimate skeletal muscle mass in patients with cirrhosis. Hepatology, 1996, 24 : 1422-1427.
52. STANLEY M.M., OCHI S., LEE K.K., NEMCHAUSKY B.A., GREENLEE H.B., ALLEN J.I., ALLEN M.J., BAUM R.A., GADACZ T.R., CAMARA D.S. Peritoneovenous shunting as compared with medical treatment in patients with alcoholic cirrhosis and massive ascites. N. Engl. J. Med., 1989, 321 : 1632-1638.
53. CARDENAS A., ARROYO V. Refractory ascites. Dig. Dis., 2005, 23 : 30-38.
54. GINES P., URIZ J., CALAHORRA B., GARCIA-TSAO G., KAMATH P.S., DEL ARBOL L.R., PLANAS R., BOSCH J., ARROYO V., RODES J. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis. Gastroenterology, 2002, 123 : 1839-47.
55. GINES P., CARDENAS A., ARROYO V., RODES J. Management of cirrhosis and ascites. N. Engl J. Med., 2004, 350 : 1646-1654.
56. CARDENAS A., GINES P. Management of refractory ascites. Clin. Gastroenterol. Hepatol., 2005, 3 : 1187-91.
57. GINES P., TITO L., ARROYO V., PLANAS R., PANES J., VIVER J., TORRES M., HUMBERT P., RIMOLA A., LLACH J. Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis. Gastroenterology, 1988, 94 : 1493-502.
58. SIMON D.M., MCCAIN J.R., BONKOVSKY H.L., WELLS J.O., HARTLE D.K., GALAMBOS J.T. Effects of therapeutic paracentesis on systemic and hepatic hemodynamics and on renal and hormonal function. Hepatology, 1987, 7 : 423-9.
59. PELTEKIAN K.M., WONG P., LIU P.P., LOGAN A.G., SHERMAN M., BLENDIS L.M. Cardiovascular, renal, and neurohumoral responses to single large-volume paracentesis in patients with cirrhosis and diuretic-resistant ascites. Am. J. Gastroenterol., 1997, 92 : 394-9.
60. ROSSLE M., OCHS A., GULBERG V., SIEGERSTETTER V., HOLL J., DEIBERT P., OLSCHEWSKI M., REISER M., GERBES A.L. A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites. N. Engl. J. Med., 2000, 342 : 1701-7.
61. SANYAL A.J., GENNING C., REDDY K.R., WONG P., KOWDLEY K.V., BENNER K., MC CASHLAND T. The North American Study for the Treatment of Refractory Ascites. Gastroenterology, 2003, 124 : 634-41.
62. SALERNO F., MERLI M., RIGGIO O., CAZZANIGA M., VALERIANO V., POZZI M., NICOLINI A., SALVATORI F. Randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites. Hepatology, 2004, 40 : 629-35.
63. MALINCHOC M., KAMATH P.S., GORDON F.D., PEINE C.J., RANK J., TER BORG P.C. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology, 2000, 31 : 864-71.
64. SHIFFMAN M.L., JEFFERS L., HOOFNAGLE J.H., TRALKA T.S. The role of transjugular intrahepatic portosystemic shunt for treatment of portal hypertension and its complications : a conference sponsored by the National Digestive Diseases Advisory Board. Hepatology, 1995, 22 : 1591-7.
65. BOYER T.D., HASKAL Z.J. The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension. Hepatology, 2005, 41 : 386-400.
66. STANLEY M.M., OCHI S., LEE K.K., NEMCHAUSKY B.A., GREENLEE H.B., ALLEN J.I., ALLEN M.J., BAUM R.A., GADACZ T.R., CAMARA D.S. Peritoneovenous shunting as compared with medical treatment in patients with alcoholic cirrhosis and massive ascites. N. Engl. J. Med., 1989, 321 : 1632-8.
67. GINES P., ARROYO V., VARGAS V., PLANAS R., CASAFONT F., PANES J., HOYOS M., VILADOMIU L., RIMOLA A., MORILLAS R. Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites. N. Engl. J. Med., 1991, 325 : 829-35.
68. D'AMICO G., MORABITO A., PAGLIARO L., MARUBINI E. Survival and prognostic indicators in compensated and decompensated cirrhosis. Dig. Dis. Sci., 1986, 31 : 468-475.